TITLE

Clinical pharmacology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS12
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Effects and mechanisms of 2-3 butanedione monoxime on the rat thoracic aorta,' by F. Dagenais et al from the Montreal Heart Institute. Negative inotropic agent.
ACCESSION #
9708235779

 

Related Articles

  • Focus on IV ibutilide: A new antiarrhythmic agent for the acute treatment of atrial fibrillation... Chen, Bonnie P.; Chow, Moses S.S. // Formulary;Jul96, Vol. 31 Issue 7, p570 

    Focuses on intravenous ibutilide, a class III antiarrhythmic agent structurally related to sotalol which prolongs both atrial and ventricular action potential duration. Chemistry; Pharmacology; Pharmacokinetics; Clinical trials; Adverse effects; Drug interactions; Dosing and administration. ...

  • Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use. Stanton, Marshall S.; Jahangir, Arshad; Shen, Win-Kuang; Hammill, Stephen C. // Formulary;Jun98, Vol. 33 Issue 6, p534 

    Focuses on issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents in clinical use in the United States. Vaugha Williams classification of antiarrhythmic drugs; Dosage and administration; Drug interactions; Adverse effects; Initiation...

  • Implantable defibrillators for ventricular arrhythmias. Kirchner, Jeffrey T. // American Family Physician;4/1/1998, Vol. 57 Issue 7, p1654 

    Presents a summary of the article `A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias,' from the New England Journal of Medical dated November 1997.

  • Antiarrhythmics. Yacone-Morton, Linda Ann; Hurley, Mary Lou // RN;Apr95, Vol. 58 Issue 4, p26 

    Focuses on the commonly used antiarrhythmics. Prototypes of each group. Side effects and nursing considerations; Role in managing electrical abnormalities; Mechanism of action; Efficacy and potency.

  • Antiarrhythmics. Chase, Sandra; Cerrato, Paul L. // RN;May97, Vol. 60 Issue 5, p41 

    Discusses the classifications of antiarrhythmic medications. Electrophysiological effects; Nursing interventions for patients receiving antiarrhythmic medications.

  • Focus on dofetilide. Tran, Hieu T.; Chow, Moses S.S. // Hospital Formulary;Jan95, Vol. 30 Issue 1, p23 

    Features the drug Dofetilide, a selective class III antiarrhythmic agent. Chemistry; Pharmacology; Pharmacokinetics and pharmacodynamics; Clinical trials; Adverse effects; Drug interactions; Dosage and administration; Formulary considerations. INSET: Formulary considerations..

  • Antiarrhythmic prescribing in Italy and Sweden.  // PharmacoEconomics & Outcomes News;9/29/2012, Issue 663, p7 

    The article discusses a difference on the prescription of antiarrhythmics in Italy and Sweden.

  • Amiodarone reduces deaths in CHF patients with high heart rates. Nul, D. R.; Doval, H. C.; Leibovitch, Eric R. // Formulary;Sep97, Vol. 32 Issue 9, p996 

    Investigates on the how antiarrhytmic amiodarone reduces mortality in patients with severe congestive heart failure. Effect of drug on percentage of mortality; Recommendation of authors on use of drug.

  • Antiarrhythmic, dyslipidemic agents.  // Formulary;Nov2002, Vol. 37 Issue 11, p600 

    Lists antiarrhythmic, dyslipidemic drugs. Brand name; Product type; Indications.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics